Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Total Liabilities (2017 - 2025)

Mesoblast's Total Liabilities history spans 6 years, with the latest figure at $165.1 million for Q2 2022.

  • For Q2 2022, Total Liabilities rose 1.09% year-over-year to $165.1 million; the TTM value through Jun 2022 reached $165.1 million, up 1.09%, while the annual FY2022 figure was $165.1 million, 1.09% up from the prior year.
  • Total Liabilities for Q2 2022 was $165.1 million at Mesoblast, up from $163.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $184.3 million in Q2 2020 and bottomed at $146.4 million in Q2 2018.
  • The 5-year median for Total Liabilities is $165.1 million (2022), against an average of $166.0 million.
  • The largest annual shift saw Total Liabilities grew 16.82% in 2019 before it dropped 11.37% in 2021.
  • A 5-year view of Total Liabilities shows it stood at $146.4 million in 2018, then rose by 16.82% to $171.1 million in 2019, then rose by 7.72% to $184.3 million in 2020, then fell by 11.37% to $163.3 million in 2021, then grew by 1.09% to $165.1 million in 2022.
  • Per Business Quant, the three most recent readings for MESO's Total Liabilities are $165.1 million (Q2 2022), $163.3 million (Q2 2021), and $184.3 million (Q2 2020).